IL22 and irritable bowel syndrome: Another 2021 study published in Turkey [64] followed children in the evolution of chronic inflammatory bowel disease (IBS) and cytokine-mediated inflammation (interleukin (IL)-1β, IL-12, IL-21, IL-22, IL -23, IL-17A, IL-17F).